Best in 7 days AOD-9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is US$ 23.01 Sold : Login>>
Best in 7 days AOD‑9604 Peptide for Fat Loss: Mechanism, Benefits & Risks Explained US$ 23.15 Sold : Login>>
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions US$ 29.31 Min. order: 1 piece ★★★★★ 4.0 (129 reviews) Sold : Login>>
Emerging trends on nanomaterial-based simultaneous electrochemical sensing of dopamine and acetaminophen US$ 24.41 Min. order: 1 piece ★★★★★ 4.0 (144 reviews) Sold : Login>>
BPC-157 & The Gut-Brain Axis: A Practitioner's Definitive Review of the Evidence US$ 23.18 Min. order: 1 piece ★★★★★ 4.1 (39 reviews) Sold : Login>>
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review US$ 26.80 Min. order: 1 piece ★★★★★ 4.7 (292 reviews) Sold : Login>>